July 18, 2017
The white paper attempts to infer the biosimilar play of India-based biosimilar developers. It explores plausible scenarios for Indian developers entering the lucrative US and EU biosimilar market based on the current situation analysis of major biosimilar developers.
July 18, 2017
Biologics have a growing share in the pharma pipeline and increased usage as nutraceuticals. The increasing demand for biologic products has attracted huge investments in capacity and capability build-up. There remains huge opportunity for service providers/CMOs to be leveraged by providing flexibile, high-quality product delivery with customer centricity.
July 18, 2017
This paper attempts to present situation analysis of the current marketplace of Oncology biosimilars specially with respect to the industry’s micro-environment. The research and analysis herein, intends to identify positive forces and interactions that are shaping an attractive biosimilar industry in both US and EU markets.